Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_assertion type Assertion NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_head.
- NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_assertion description "[Although prolactin is likely to be one of several predisposing factors in the pathogenesis and progression of SLE, this suggests that manipulation of lymphocyte prolactin production (rather than pituitary production) might be a useful therapeutic approach.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_provenance.
- NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_assertion evidence source_evidence_literature NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_provenance.
- NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_assertion SIO_000772 11721693 NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_provenance.
- NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_assertion wasDerivedFrom befree-20140225 NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_provenance.
- NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_assertion wasGeneratedBy ECO_0000203 NP232702.RAY8lDZg2Rrv2XoqU2o960EZ-_AwQE38DNLl1yzi2jBqA130_provenance.